Canopy Growth Corporation vs Johnson & Johnson — Stock Comparison
Q·Score Breakdown
4
Bearish
Overall
7.1
Bullish
Quality
Health
Growth
Valuation
Sentiment
CGC
Clean balance sheet with low leverage (0.3× debt-to-equity).
⚠ currently unprofitable (-117% margin).
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
HOLD
Target $1.81 (+60.0%)
1 analysts
BUY
Target $252.42 (+11.1%)
24 analysts
Fundamentals
CGC
JNJ
—
Trailing P/E
26.3×
-15.5×
Forward P/E
17.9×
-117.3%
Profit Margin
21.8%
26.6%
Gross Margin
68.0%
-48.5%
ROE
26.4%
-0.3%
Revenue Growth
9.9%
—
Earnings Growth
-52.9%
2.32
Beta
0.33
—
Price / Book
—
$507M
Market Cap
$546.9B
$1 – $2
52-Week Range
$146 – $252
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →